Compare DRMA & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRMA | SINT |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | United States |
| Employees | 8 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5M | 11.7M |
| IPO Year | N/A | 2007 |
| Metric | DRMA | SINT |
|---|---|---|
| Price | $1.21 | $2.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $10.00 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 1.8M | 28.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,887,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $80.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 9.90 |
| 52 Week Low | $0.59 | $1.72 |
| 52 Week High | $7.33 | $6.78 |
| Indicator | DRMA | SINT |
|---|---|---|
| Relative Strength Index (RSI) | 43.20 | 39.33 |
| Support Level | $1.11 | $2.58 |
| Resistance Level | $2.29 | $2.94 |
| Average True Range (ATR) | 0.08 | 0.13 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 56.25 | 25.00 |
Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology for patients suffering with acne. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.